ArticleFrontiers in pharmacology2023

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7.

Balaji Chandrasekaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.